Out of nearly 36,000 people hospitalized for heart attacks, most didn't get a cholesterol drug called ezetimibe—even though almost all were already on strong statins. Only about 1 in 6 got it early, and a similar number got it later.

If someone has a heart attack and starts taking a cholesterol drug called ezetimibe within 3 months, they’re less likely to have another heart problem in the next 3 years compared to those who wait longer or never start it.

People who had a heart attack and started taking a cholesterol drug called ezetimibe early had fewer heart problems over the next year compared to those who started later or didn’t take it at all.

If someone has a heart attack and hasn’t taken cholesterol drugs before, waiting more than 12 weeks to start a drug called ezetimibe might increase their risk of future heart problems — though the data isn’t strong enough to be sure.

If you've had a heart attack, starting a cholesterol drug called ezetimibe within 3 months might lower your chance of dying from heart problems over the next 3 years, compared to waiting or not taking it at all.

For people who've had a recent heart problem, taking ezetimibe with their cholesterol medicine (a statin) helps prevent heart attacks and strokes over 7 years — and doesn't seem to cause extra cancer or liver issues.